Insider trade

Officer received an award of 19K BSX derivative securities

Traded Feb 12, 2026 · Filed Feb 18, 2026

Boston ScientificBSX

19K
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 12, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 18, 2026

OfficerGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001225208-26-002015
Filed / recorded

Feb 18, 2026, 12:06 AM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

BOSTON SCIENTIFIC CORP

Issuer CIK

885725

Ticker

BSX

Reporting person

Joseph Michael Fitzgerald

Relationship

Officer

Officer title

EVP & Group Pres, Cardiology

Security

Restricted Stock Units

Table

Derivative (Table II)

Transaction date

Feb 12, 2026

Transaction code

A

Shares / units

18,550

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

18,550

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.